Provectus Receives Patent for Manufacture of PV-10 Active Ingredient

Provectus pic


Peter Culpepper was a management consultant at Felix Culpepper International before joining Provectus Biopharmaceuticals in 2004 as corporate officer/CFO. Under Peter Culpepper’s stewardship, Provectus Biopharmaceuticals received a patent for the manufacturing of PV-10’s active ingredient.

A company specializing in the development of oncology and dermatology therapies, Provectus Biopharmaceuticals was successful in getting a U.S Patent and Trademark Office patent covering its use of a unique element in the manufacture of the active ingredient API for PV-10. The unique ingredient is being used in all clinical trials for PV-10, which is a proposed therapy for metastatic melanoma.

The patent granted to Provectus Biopharmaceuticals, Patent No. 9,273,022, is valid until 2031. It guarantees protection for the commercial manufacture of PV-10.

A critical part of any new drug is the Chemistry, Manufacturing, and Controls. This is where scientists work to enable the manufacturing of active ingredients in drugs, leading to ground-breaking techniques that can be patented.

Provectus Biopharmaceuticals worked closely with Cambrex Charles City, Inc., to bring the patent application process to fruition. Cambrex Charles City provides services that improve both the initial development and later commercialization of therapeutics.


The 2016 AICPA Employee Benefits Plan Conference

American Institute of CPAs pic

American Institute of CPAs

Certified Public Accountant (CPA) Peter Culpepper has had a long career in finance. The chief financial officer of Provectus Biopharmaceuticals, Peter Culpepper is a member of the American Institute of CPAs (AICPA).

Every year, the AICPA Employee Benefits Plans Conference is organized to address the issues affecting the practice of auditing and tax compliance. This year’s conference will be held on May 10-12, 2016, at the ARIA Resort & Casino in Las Vegas, Nevada. The conference will offer insights into how companies can approach audit and tax compliance to meet even the highest level of scrutiny.

Speakers at the conference will include AICPA senior vice president of public practice Susan Coffey, Spaulding Companies Corporation president Tommy Spaulding, and PricewaterhouseCoopers senior strategic advisor Hon. David Walker. Every session will be customized by skill level and accountancy proficiency. CPAs, tax professionals, auditors, and financial reporting consultants are invited to attend the AICPA Employee Benefits Plans Conference.